MR Safe Robot, FDA Clearance, Safety and Feasibility of Prostate Biopsy Clinical Trial

Dan Stoianovici, Chunwoo Kim, Doru Petrisor, Changhan Jun, Sunghwan Lim, Mark W. Ball, Ashley Ross, Katarzyna Macura, Mohamad E Allaf

Research output: Contribution to journalArticle

Abstract

Compatibility of mechatronic devices with the MR environment has been a very challenging engineering task. After over a decade of developments, we report the successful translation to clinical trials of our MR safe robot technology. MrBot is a six degree of freedom, pneumatically actuated robot for transperineal prostate percutaneous access, built exclusively of electrically nonconductive and nonmagnetic materials. Its extensive preclinical tests have been previously reported. Here, we present the latest technology developments, an overview of the regulatory protocols, and technically related results of the clinical trial. The Food and Drug Administration (FDA) has approved the MrBot for the biopsy trial, which was successfully performed in five patients. With no trajectory corrections and no unsuccessful attempts to target a site, the robot achieved an MRI-based needle targeting accuracy of 2.55 mm. To the best of our knowledge, this is the first robot approved by the FDA for the MR environment. The results confirm that it is possible to perform safe and accurate robotic manipulation in the MRI scanner, and the development of MR safe robots is no longer a daunting technical challenge.

Original languageEnglish (US)
Article number7592911
Pages (from-to)115-126
Number of pages12
JournalIEEE/ASME Transactions on Mechatronics
Volume22
Issue number1
DOIs
StatePublished - Feb 1 2017

Fingerprint

Biopsy
Robots
Magnetic resonance imaging
Mechatronics
Needles
Robotics
Trajectories

Keywords

  • Clinical trial
  • Food and Drug Administration (FDA)
  • magnetic resonance imaging (MRI) compatible
  • medical robotics
  • motor
  • MR safe
  • pneumatic
  • prostate biopsy
  • robot

ASJC Scopus subject areas

  • Control and Systems Engineering
  • Computer Science Applications
  • Electrical and Electronic Engineering

Cite this

MR Safe Robot, FDA Clearance, Safety and Feasibility of Prostate Biopsy Clinical Trial. / Stoianovici, Dan; Kim, Chunwoo; Petrisor, Doru; Jun, Changhan; Lim, Sunghwan; Ball, Mark W.; Ross, Ashley; Macura, Katarzyna; Allaf, Mohamad E.

In: IEEE/ASME Transactions on Mechatronics, Vol. 22, No. 1, 7592911, 01.02.2017, p. 115-126.

Research output: Contribution to journalArticle

@article{6b60728ea9f44b748ff4ab685b57305f,
title = "MR Safe Robot, FDA Clearance, Safety and Feasibility of Prostate Biopsy Clinical Trial",
abstract = "Compatibility of mechatronic devices with the MR environment has been a very challenging engineering task. After over a decade of developments, we report the successful translation to clinical trials of our MR safe robot technology. MrBot is a six degree of freedom, pneumatically actuated robot for transperineal prostate percutaneous access, built exclusively of electrically nonconductive and nonmagnetic materials. Its extensive preclinical tests have been previously reported. Here, we present the latest technology developments, an overview of the regulatory protocols, and technically related results of the clinical trial. The Food and Drug Administration (FDA) has approved the MrBot for the biopsy trial, which was successfully performed in five patients. With no trajectory corrections and no unsuccessful attempts to target a site, the robot achieved an MRI-based needle targeting accuracy of 2.55 mm. To the best of our knowledge, this is the first robot approved by the FDA for the MR environment. The results confirm that it is possible to perform safe and accurate robotic manipulation in the MRI scanner, and the development of MR safe robots is no longer a daunting technical challenge.",
keywords = "Clinical trial, Food and Drug Administration (FDA), magnetic resonance imaging (MRI) compatible, medical robotics, motor, MR safe, pneumatic, prostate biopsy, robot",
author = "Dan Stoianovici and Chunwoo Kim and Doru Petrisor and Changhan Jun and Sunghwan Lim and Ball, {Mark W.} and Ashley Ross and Katarzyna Macura and Allaf, {Mohamad E}",
year = "2017",
month = "2",
day = "1",
doi = "10.1109/TMECH.2016.2618362",
language = "English (US)",
volume = "22",
pages = "115--126",
journal = "IEEE/ASME Transactions on Mechatronics",
issn = "1083-4435",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
number = "1",

}

TY - JOUR

T1 - MR Safe Robot, FDA Clearance, Safety and Feasibility of Prostate Biopsy Clinical Trial

AU - Stoianovici, Dan

AU - Kim, Chunwoo

AU - Petrisor, Doru

AU - Jun, Changhan

AU - Lim, Sunghwan

AU - Ball, Mark W.

AU - Ross, Ashley

AU - Macura, Katarzyna

AU - Allaf, Mohamad E

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Compatibility of mechatronic devices with the MR environment has been a very challenging engineering task. After over a decade of developments, we report the successful translation to clinical trials of our MR safe robot technology. MrBot is a six degree of freedom, pneumatically actuated robot for transperineal prostate percutaneous access, built exclusively of electrically nonconductive and nonmagnetic materials. Its extensive preclinical tests have been previously reported. Here, we present the latest technology developments, an overview of the regulatory protocols, and technically related results of the clinical trial. The Food and Drug Administration (FDA) has approved the MrBot for the biopsy trial, which was successfully performed in five patients. With no trajectory corrections and no unsuccessful attempts to target a site, the robot achieved an MRI-based needle targeting accuracy of 2.55 mm. To the best of our knowledge, this is the first robot approved by the FDA for the MR environment. The results confirm that it is possible to perform safe and accurate robotic manipulation in the MRI scanner, and the development of MR safe robots is no longer a daunting technical challenge.

AB - Compatibility of mechatronic devices with the MR environment has been a very challenging engineering task. After over a decade of developments, we report the successful translation to clinical trials of our MR safe robot technology. MrBot is a six degree of freedom, pneumatically actuated robot for transperineal prostate percutaneous access, built exclusively of electrically nonconductive and nonmagnetic materials. Its extensive preclinical tests have been previously reported. Here, we present the latest technology developments, an overview of the regulatory protocols, and technically related results of the clinical trial. The Food and Drug Administration (FDA) has approved the MrBot for the biopsy trial, which was successfully performed in five patients. With no trajectory corrections and no unsuccessful attempts to target a site, the robot achieved an MRI-based needle targeting accuracy of 2.55 mm. To the best of our knowledge, this is the first robot approved by the FDA for the MR environment. The results confirm that it is possible to perform safe and accurate robotic manipulation in the MRI scanner, and the development of MR safe robots is no longer a daunting technical challenge.

KW - Clinical trial

KW - Food and Drug Administration (FDA)

KW - magnetic resonance imaging (MRI) compatible

KW - medical robotics

KW - motor

KW - MR safe

KW - pneumatic

KW - prostate biopsy

KW - robot

UR - http://www.scopus.com/inward/record.url?scp=85013393614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013393614&partnerID=8YFLogxK

U2 - 10.1109/TMECH.2016.2618362

DO - 10.1109/TMECH.2016.2618362

M3 - Article

C2 - 28867930

AN - SCOPUS:85013393614

VL - 22

SP - 115

EP - 126

JO - IEEE/ASME Transactions on Mechatronics

JF - IEEE/ASME Transactions on Mechatronics

SN - 1083-4435

IS - 1

M1 - 7592911

ER -